NXLLF yields 200.00% · MRK yields 2.76%● Live data
📍 NXLLF pulled ahead of the other in Year 1
Combined, NXLLF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NXLLF + MRK for your $10,000?
Nuix Limited provides investigative analytics and intelligence software solutions in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. The company offers Nuix Workstation, a solution for processing file formats and source types into meaningful information by capturing the content, metadata, and context; Nuix Discover that provides processing, analytics, and machine learning-powered review in a single platform; and Nuix Investigate, a solution which extracts, correlates, and contextualizes various types of data types, across people, objects, locations, and events. The company also provides Nuix Adaptive Security, monitors, detects, and responds to the threats of enterprises; Nuix Enterprise Collection Center, a solution to collect disk images or selected data from laptops, desktops, servers, enterprise file shares, and Microsoft sharepoint sites to legal, investigation, security, and compliance teams for investigation; Nuix Automation, a web-based multi-user graphical tool that allows to map out complex data processes across various activities and machines; and Nuix NLP, a solution which combines machine learning technologies with a proprietary language model to discover, understand, classify, and quantify text content. It serves corporations, governments, law enforcement industries, law firms, advisories, and service partners. The company was formerly known as Nuix Pty Ltd and changed its name to Nuix Limited in September 2020. Nuix Limited was founded in 2000 and is headquartered in Sydney, Australia.
Full NXLLF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.